评估由药剂师发起的慢性阻塞性肺病患者护理包。

IF 0.6 Q4 PHARMACOLOGY & PHARMACY
CANADIAN JOURNAL OF HOSPITAL PHARMACY Pub Date : 2022-10-03 eCollection Date: 2022-01-01 DOI:10.4212/cjhp.3226
Jacqueline Kwok, Michael Kammermayer, Vincent H Mabasa, Tiffany Winstone, Darwin Chan
{"title":"评估由药剂师发起的慢性阻塞性肺病患者护理包。","authors":"Jacqueline Kwok, Michael Kammermayer, Vincent H Mabasa, Tiffany Winstone, Darwin Chan","doi":"10.4212/cjhp.3226","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is a cause of significant morbidity and mortality, and management of patients with this complex disease remains a challenge. Pharmacists work within an interdisciplinary health care team to coordinate services and ensure that standards of care are met. A pharmacist-initiated care bundle provided in the outpatient setting has shown promising results in improving COPD management.</p><p><strong>Objective: </strong>To evaluate, in the acute care setting, the effectiveness of a pharmacist-initiated COPD care bundle in improving compliance with health care measures known to improve outcomes in patients with COPD.</p><p><strong>Methods: </strong>This retrospective chart review included patients with acute exacerbation of COPD admitted from May 14, 2019, to February 29, 2020. Completion rates for the 6 individual components of the COPD care bundle were compared between patients who did and did not receive the pharmacist-initiated intervention. A subgroup of 22 patients received the following additional interventions: documentation of the modified Medical Research Council score, assessment of COPD medications, and vaccination review and administration.</p><p><strong>Results: </strong>A total of 106 patients were included in the analysis, 53 patients in each of the control and intervention groups. The pharmacist-initiated intervention increased completion rates for the overall COPD care bundle from 2% to 17% (<i>p</i> = 0.003), for provision of the COPD flare-up action plan from 4% to 79% (<i>p</i> < 0.001), and for provision of smoking cessation education from 0% to 36% (<i>p</i> = 0.04); however, there was no significant difference in assessment by a respiratory therapist. For the subgroup that received additional interventions, vaccination reviews were conducted for 21 (96%) of the 22 patients, which led to 9 (41%) receiving a guideline-recommended vaccine.</p><p><strong>Conclusions: </strong>Pharmacist involvement in initiation of the care bundle significantly increased completion rates for the activities included in the care bundle.</p>","PeriodicalId":51646,"journal":{"name":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","volume":"75 4","pages":"302-308"},"PeriodicalIF":0.6000,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524560/pdf/cjhp-75-302.pdf","citationCount":"0","resultStr":"{\"title\":\"Evaluating a Pharmacist-Initiated Care Bundle for Patients with Chronic Obstructive Pulmonary Disease.\",\"authors\":\"Jacqueline Kwok, Michael Kammermayer, Vincent H Mabasa, Tiffany Winstone, Darwin Chan\",\"doi\":\"10.4212/cjhp.3226\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is a cause of significant morbidity and mortality, and management of patients with this complex disease remains a challenge. Pharmacists work within an interdisciplinary health care team to coordinate services and ensure that standards of care are met. A pharmacist-initiated care bundle provided in the outpatient setting has shown promising results in improving COPD management.</p><p><strong>Objective: </strong>To evaluate, in the acute care setting, the effectiveness of a pharmacist-initiated COPD care bundle in improving compliance with health care measures known to improve outcomes in patients with COPD.</p><p><strong>Methods: </strong>This retrospective chart review included patients with acute exacerbation of COPD admitted from May 14, 2019, to February 29, 2020. Completion rates for the 6 individual components of the COPD care bundle were compared between patients who did and did not receive the pharmacist-initiated intervention. A subgroup of 22 patients received the following additional interventions: documentation of the modified Medical Research Council score, assessment of COPD medications, and vaccination review and administration.</p><p><strong>Results: </strong>A total of 106 patients were included in the analysis, 53 patients in each of the control and intervention groups. The pharmacist-initiated intervention increased completion rates for the overall COPD care bundle from 2% to 17% (<i>p</i> = 0.003), for provision of the COPD flare-up action plan from 4% to 79% (<i>p</i> < 0.001), and for provision of smoking cessation education from 0% to 36% (<i>p</i> = 0.04); however, there was no significant difference in assessment by a respiratory therapist. For the subgroup that received additional interventions, vaccination reviews were conducted for 21 (96%) of the 22 patients, which led to 9 (41%) receiving a guideline-recommended vaccine.</p><p><strong>Conclusions: </strong>Pharmacist involvement in initiation of the care bundle significantly increased completion rates for the activities included in the care bundle.</p>\",\"PeriodicalId\":51646,\"journal\":{\"name\":\"CANADIAN JOURNAL OF HOSPITAL PHARMACY\",\"volume\":\"75 4\",\"pages\":\"302-308\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2022-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524560/pdf/cjhp-75-302.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CANADIAN JOURNAL OF HOSPITAL PHARMACY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4212/cjhp.3226\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4212/cjhp.3226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:慢性阻塞性肺病 (COPD) 是导致严重发病和死亡的原因之一,对这种复杂疾病患者的管理仍然是一项挑战。药剂师在跨学科医疗团队中协调服务,确保达到护理标准。药剂师在门诊环境中提供的护理捆绑服务在改善慢性阻塞性肺病管理方面取得了可喜的成果:目的:评估在急症护理环境中,由药剂师发起的慢性阻塞性肺病护理捆绑方案在改善慢性阻塞性肺病患者对已知可改善预后的医疗措施的依从性方面的效果:这项回顾性病历审查包括 2019 年 5 月 14 日至 2020 年 2 月 29 日入院的慢性阻塞性肺疾病急性加重患者。比较了接受和未接受药剂师主动干预的患者对慢性阻塞性肺病护理捆绑计划中 6 个单项内容的完成率。22名患者组成的亚组接受了以下额外干预:记录修改后的医学研究委员会评分、评估慢性阻塞性肺病药物以及疫苗接种审查和管理:共有 106 名患者参与了分析,其中对照组和干预组各 53 人。药剂师发起的干预将慢性阻塞性肺病整体护理捆绑包的完成率从 2% 提高到 17%(p = 0.003),将慢性阻塞性肺病发作行动计划的完成率从 4% 提高到 79%(p < 0.001),将戒烟教育的完成率从 0% 提高到 36%(p = 0.04);但是,呼吸治疗师的评估结果没有显著差异。在接受额外干预的亚组中,对 22 名患者中的 21 人(96%)进行了疫苗接种审查,结果有 9 人(41%)接种了指南推荐的疫苗:结论:药剂师参与护理包的启动大大提高了护理包所含活动的完成率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Evaluating a Pharmacist-Initiated Care Bundle for Patients with Chronic Obstructive Pulmonary Disease.

Evaluating a Pharmacist-Initiated Care Bundle for Patients with Chronic Obstructive Pulmonary Disease.

Evaluating a Pharmacist-Initiated Care Bundle for Patients with Chronic Obstructive Pulmonary Disease.

Background: Chronic obstructive pulmonary disease (COPD) is a cause of significant morbidity and mortality, and management of patients with this complex disease remains a challenge. Pharmacists work within an interdisciplinary health care team to coordinate services and ensure that standards of care are met. A pharmacist-initiated care bundle provided in the outpatient setting has shown promising results in improving COPD management.

Objective: To evaluate, in the acute care setting, the effectiveness of a pharmacist-initiated COPD care bundle in improving compliance with health care measures known to improve outcomes in patients with COPD.

Methods: This retrospective chart review included patients with acute exacerbation of COPD admitted from May 14, 2019, to February 29, 2020. Completion rates for the 6 individual components of the COPD care bundle were compared between patients who did and did not receive the pharmacist-initiated intervention. A subgroup of 22 patients received the following additional interventions: documentation of the modified Medical Research Council score, assessment of COPD medications, and vaccination review and administration.

Results: A total of 106 patients were included in the analysis, 53 patients in each of the control and intervention groups. The pharmacist-initiated intervention increased completion rates for the overall COPD care bundle from 2% to 17% (p = 0.003), for provision of the COPD flare-up action plan from 4% to 79% (p < 0.001), and for provision of smoking cessation education from 0% to 36% (p = 0.04); however, there was no significant difference in assessment by a respiratory therapist. For the subgroup that received additional interventions, vaccination reviews were conducted for 21 (96%) of the 22 patients, which led to 9 (41%) receiving a guideline-recommended vaccine.

Conclusions: Pharmacist involvement in initiation of the care bundle significantly increased completion rates for the activities included in the care bundle.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CANADIAN JOURNAL OF HOSPITAL PHARMACY
CANADIAN JOURNAL OF HOSPITAL PHARMACY PHARMACOLOGY & PHARMACY-
CiteScore
1.10
自引率
0.00%
发文量
64
期刊介绍: The CJHP is an academic journal that focuses on how pharmacists in hospitals and other collaborative health care settings optimize safe and effective drug use for patients in Canada and throughout the world. The aim of the CJHP is to be a respected international publication serving as a major venue for dissemination of information related to patient-centred pharmacy practice in hospitals and other collaborative health care settings in Canada and throughout the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信